Skip to main content
Log in

Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats

  • Original Paper
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

The pharmacokinetic interaction of enrofloxacin and trimethoprim was evaluated after single-dose intraperitoneal or oral co-administration in rats. Plasma concentrations of the two drugs were determined by high-performance liquid chromatography. Following intraperitoneal combination, a significant (P < 0.05) increase in mean values of plasma half-life (t 1/2) and maximum plasma concentration (C max) was observed for enrofloxacin and trimethoprim, respectively. There was a significant (P < 0.05) increase in mean values of area under the plasma drug concentration versus time from time zero to infinity (AUC0–∞) and C max between combined oral doses (10, 30 and 100 mg/kg) of both antibacterial drugs. Also, after oral conjugation a significant difference in mean values of MRT0–∞ was observed between lower (10 mg/kg) and higher (100 mg/kg) doses of both drugs. A significant increase in pharmacokinetic parameters of both drugs in combined intraperitoneal and oral doses indicated pharmacokinetic interaction of enrofloxacin and trimethoprim. Further study is recommended in other species of animals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abo K, El Sooud, Al-Anati L (2011) Effect of flunixin on the disposition of enrofloxacin in calves. Insight Vet Res 1:1–4

    Article  Google Scholar 

  • Abu-Basha EA, Gehring R, Hantash TM, Al-Shunnaq AF, Idkaidek NM (2009) Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches. J Vet Pharmacol Ther 32:258–263

    Article  CAS  PubMed  Google Scholar 

  • Anca M, Răpuntean GH, Oros NA, Cernea M (2007) Investigations on the synergic effects of aminoglycosides, polymyxins and fluoroquinolones combinations against pseudomonas aeruginosaisolated from dog. Lucrări ştiinłifice medicină veterinară 40:99

    Google Scholar 

  • Anu R, Amit K, Ahmad AH, Malik JK (2007) Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep. Res Vet Sci 84:452–456

    Google Scholar 

  • Atef M, Al-khayyat AA, Fahd K (2010) Pharmacokinetics and tissue distribution of trimethoprim in sheep. Transbound Emerg Dis 25:509–596

    Google Scholar 

  • Batzias GC, Delis GA, Koutsoviti-Papadopoulou M (2005) Bioavailability and pharmacokinetics of sulfadiazine, N4-acetyl sulfadiazine and trimethoprim following intravenous and intramuscular administration of a sulfadiazine/trimethoprim combination in sheep. Vet Res Commun 29:699–712

    Article  CAS  PubMed  Google Scholar 

  • Bermingham EC, Papich MG (2002) Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. Am J Vet Res 63:1012–1017

    Article  CAS  PubMed  Google Scholar 

  • Bista D, Palaian S, Shankar PR, Prabhu MM, Paudel R, Mishra P (2006) Understanding the essentials of drug interactions: a potential need for safe and effective use of drugs. KUMJ 4:421–430

    Google Scholar 

  • Brooks MA, De Silva JAF, D’Arconte LM (1972) Determination of trimethoprim and its N-oxide metabolites in urine of man, dog, and rat by differential pulse polarography. J Pharm Sci 62:1395–1397

    Article  Google Scholar 

  • Choi MJ, Sileshi B, Lee SJ, Dereje D, Reza MA, Rhee MH, Kim TH, Park SCP (2012) The in vitro antibacterial activity of enrofloxacin–trimethoprim combination against five bacterial species. PVJ 32:363–366

    CAS  Google Scholar 

  • Defeng Z, Aihua L, Jun X, Cheng J (2010) In vitro antibacterial effect of berberine hydrochloride and enrofloxacin to fish pathogenic bacteria. Aquac Res 41:1095–1100

    Google Scholar 

  • Eliopoulos GM (1989) Synergism and antagonism. Infect Dis Clin North Am 3:399–406

    CAS  PubMed  Google Scholar 

  • Eliopoulos GM, Wennersten CB (1997) In vitro activity of trimethoprim alone compared with trimethoprim–sulfamethoxazole and other antimicrobials against bacterial species associated with upper respiratory tract infections. Diagn Microbiol Infect Dis 28:33–38

    Article  Google Scholar 

  • Elmas M, Tras B, Kaya S, Bas AL, Yazar E, Yarsan E (2001) Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats. Can J Vet Res 65:64–67

    CAS  PubMed Central  PubMed  Google Scholar 

  • Eoin PQ, Joseph M, Donald GW, John S (2000) Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J 14:2519–2524

    Article  Google Scholar 

  • Hooper CD (2001) Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 32:9–15

    Article  Google Scholar 

  • Huovinen R, Wolfsont JS, Hooper DC (1992) Synergism of trimethoprim and ciprofloxacin In Vitro against clinical bacterial isolates. Eur J Clin Microbiol Infect Dis 11:255–257

    Article  CAS  PubMed  Google Scholar 

  • Jaiprakash N, Nirbhay K, Jha HN, Jaya C (2009) Effect of probenecid on kinetics of enrofloxacin in lactating goats after Sc administration. Indian J Exp Biol 47:53–56

    Google Scholar 

  • Lin JH, Lu AY (1998) Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–390

    Article  CAS  PubMed  Google Scholar 

  • Ling–Ling Z, Jun-Ren Z, Kuan G, Hui J, Yan Z, Shan-Xiang J (2011) Effects of fluoroquinolones on CYP4501A and 3A in male broilers. Res Vet Sci 90:99–105

    Article  Google Scholar 

  • McKellar Q (1996) Clinical relevance of the pharmacologic properties of fluoroquinolones. Suppl Compend Contin Educ Pract Vet 18:14–20

    Google Scholar 

  • Meret MF, Ju¨rgen B, Reinhard D, Ruth F, Gerd M, Ingeborg WS, Walter EH (2002) Dose-dependent increase of saquinavir bioavailability by the pharmaceutical aid cremophor EL. Br J Clin Pharmacol 53:576–581

    Article  Google Scholar 

  • Meshi T, Sato Y (1972) Studies on sulphamethoxazole/trimethoprim. Absorption, distribution, excretion, and metabolism of trimethoprim in rat. Chem Pharm Bull 20:2079–2090

    Article  CAS  PubMed  Google Scholar 

  • Mikko N, Janne TB, Pertti JN (2004) Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone. Clin Pharmacol Ther 76:239–249

    Article  Google Scholar 

  • Ogino T, Arai T (2007) Pharamcokinetic interactions of flunixin meglumine and enrofloxacin in ICR mice. Exp Anim 56:79–84

    Article  CAS  PubMed  Google Scholar 

  • Post LO, Farrell DE, Cope CV, Baker JD, Myers MJ (2003) The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. J Pharmacol Exp Ther 304:889–895

    Article  CAS  PubMed  Google Scholar 

  • Sanjib K, Chandana CB, Khanikar HN, Mohan P (2008) Kinetic studies of enrofloxacin after intravenous administration in yak. Pharmacol Online 3:545–551

    Google Scholar 

  • Sharma PK, Ahmad AH, Sharma LD, Varma R (2003) Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves. Vet J 166:101–104

    Article  CAS  PubMed  Google Scholar 

  • Shyampada M, Nishith KP, Imran H, Chowdhury IH, Manisha D (2009) Antibacterial activity of ciprofloxacin and trimethoprim alone and in combination against Vibrio cholerae 01 biotype E1 Tor sero type Ogawa isolates. PJM 58:57–60

    Google Scholar 

  • Tyczkowska K, Hedeen KM, Aucoin DP, Aronson AL (1989) High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J Chromatogr 493:337–346

    Article  CAS  PubMed  Google Scholar 

  • Vancutsem PM, Babish JG, Schwark WS (1990) The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 80:173–186

    CAS  PubMed  Google Scholar 

  • Vandevenne M, Vandenbussche H, Verstraete A (2000) Detection time of drugs of abuse in urine. Acta Clin Belg 55:323–333

    CAS  PubMed  Google Scholar 

  • Wen X, Wang JS, Backman JT, Jouko L, Pertti JN (2002) Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9 respectively. Drug Metab Dispos 30:631–635

    Article  CAS  PubMed  Google Scholar 

  • Wendy MB, Stephen HW (2002) The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. J Biol Chem 277:22491–22496

    Article  Google Scholar 

Download references

Acknowledgments

This research was supported in part by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0021670), in part by the Next-Generation BioGreen 21 Program (No. PJ009007).

Conflict of interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung-Chun Park.

Additional information

M.-J. Choi and B. Yohannes contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, MJ., Yohannes, S.B., Lee, SJ. et al. Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats. Eur J Drug Metab Pharmacokinet 39, 11–16 (2014). https://doi.org/10.1007/s13318-013-0142-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-013-0142-0

Keywords

Navigation